Against Influenza in children, which actions?;Contre la grippe de l'enfant: Quelles actions?

Archives de Pediatrie

Volumn 11, Issue 5, 2004, Pages 480-488

  Weil Olivier, C ^a  

^a NONE

Author keywords

Anti neuraminidases; Children; High risk children; Influenza; Influenza vaccine

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; IBUPROFEN; INFLUENZA VACCINE; OSELTAMIVIR; PARACETAMOL; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; ENCEPHALITIS; EPIDEMIC; FEBRILE CONVULSION; FEVER; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS; LUNG DISEASE; MYOSITIS; OTITIS MEDIA; OUTPATIENT; RESPIRATORY TRACT DISEASE; RISK FACTOR; VIRUS MYOCARDITIS;

EID: 2342496745     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2003.12.006     Document Type: Article

References (51)

1. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr InfectDisJ 1997;16:1065-8.
2. Nicholson KG. Managing Influenza in Primary Care. Blackwell Science; 1999.
3. Olivier C. La grippe chez l'enfant. virologie septembre 2002 n° spécial.
4. Vesa S, Kleemola M, Blomqvist S, Takala A, Kilpi T, Hovi T. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J 2001;20:574-81.
5. Heikkinen T, Chonmaitree T. Viruses and otitis media. Pediatr Infect Dis J 2000;19:1005-7.
6. Chiu SS, Tse CYC, Lau YL, Peiris M. Influenza A infection is an important cause of febrile seizures. Pediatrics 2001;108:E63.
7. Edwards KT, Poehling KA. Influenza virus continues to pose new challenges. Pediatrics 2001;108:1004-5.
8. Yoshikawa H, Yamazaki S, Watanabe T, Abe T. Study of influenza-associated encephalitis/encephalopathy in children during the 1997 to 2001 influenza seasons. J Child Neurol 2001;16(12):885-90.
9. Manuguerra JC, Mosnier A. Épidémiologie de la grippe et réseaux de surveillance. Livre infections virales respiratoires, tome 1. Grippe et infections virales des voies aériennes supérieures, coordinateur : Freymuth F., Ed. scientifiques et médicales Elsevier; 2001. p. 75-87.
10. Glezen WP. Influenza viruses. In: Feigin J, Cherry D, editors. Text Book of pediatrics infectious diseases, II. Saunders Ed; 1998. p. 2024-41.
11. Bricaire F, Zeller V. La clinique de la grippe et son diagnostic. Livre infections virales respiratoires, tome 1. Grippe et infections virales des voies aériennes supérieures, coordinateur : Freymuth F., Ed. scientifiques et médicales Elsevier; 2001. p. 43-8.
12. Aymard M. Physiopathologie de la grippe et diagnostic virologique. Livre infections virales respiratoires, tome 1. Grippe et infections virales des voies aériennes supérieures : Freymuth F., Ed. scientifiques et médicales Elsevier; 2001. p. 61-73.
13. Gruber WC. Children as a target for immunization in Texbook of Influenza. In: Nicholson KG, Webster RG, Hay AJ, editors. Blackwell science Ltd; 1998. p. 435-45.
14. Glezen WP, Taber LH, Frank AL, Gruber WC, Piedra PA. Influenza virus infections in infants. Pediatr Infect Dis J 1997;16:1065-8.
15. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against Influenza. N Engl J Med 2001;344:889-96.
16. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effect of Influenza on hospitalisations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
17. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, De Stefano F, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
18. Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002;185(2):147-52.
19. Simoes EA. Overlap between respiratory syncytial virus infection and influenza. Lancet 2001;258:1382-3.
20. Van Der Werf S., Manuguerra J.C. (Institut Pasteur). Report on the surveillance of influenza in Northern France 2001/2002 season (weeks 2001/04 to 2002/04). Informal meeting on the WHO recommendation on the composition of inactivated influenza vaccines for use in the season 2002/2003. Geneva, 6th February 2002.
21. Lina B. Traitement antiviral et prévention de la grippe. Livre Infections virales respiratoires, tome 1. Grippe et infections virales des voies aériennes supérieures : Freymuth F., Ed. scientifiques et médicales Elsevier; 2001. p. 89-98.
22. Garcia Garcia ML, Ordobas Gabin M, Calvo Reya C, Gonzalez Alvarez M, Aguilar Ruiz J, Arregui Sierra A, et al. Viral infection of the lower respiratory tract in hospitalized infants: etiology, clinical features and risk factors. An Esp Pediatr 2001;55(2):101-7.
23. Prevention and control of Influenza. Recommendations of the advisory committee on immunization practices (ACIP). MMWR 2002;51(n° RR- 3).
24. Calendrier vaccinal 2000 BEH, Février 2002 n° 6.
25. Poland GA, Rottighaus ST, Jacobson RM. Influenza vaccines: a review and rationale for use in developed and underdeveloped countries. Vaccine 2001;19(17-19):2216-20.
26. Clements DA, Langdon L, Bland C? Walter E. Influenza A vaccine decreases the incidence of otitis media in 6 to 30 month old children in day care. Arch Pediatr adolesc med 1995;149:1113-6.
27. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, HalomneN P. Influenza vaccination in the prevention of acute otitis media in children. AJDS 1991;145:445-8.
28. The American Lung Association Asthma Clinical Research Centers. the safety of inactivated Influenza vaccine in adults and children with asthma. N EngJ Med 2001;345:1529-36.
29. Glezen P. Influenza vaccination for healthy children. Current opinion in infectious diseases 2002;15:283-7.
30. Subbarao K. As good as the real thing. J Pediatr 2000;136:139-41.
31. Intosh MK, Lieu T. Is it time to give Influenza vaccine to healthy infants? N Eng J Med 2000;342:275-6.
32. Boyce TG, Poland GA. Promises and challenges of live attenuated intranasal Influenza vaccines across the age spectrum: a review. Biomed pharmacother 2000;54:210-8.
33. Zhdanov VM. Live influenza vaccines in USSR: development of studies and practical applications. In: Kendal AP, Patriarca P, editors. Options for the Control of Influenza. New York: Alan Liss; 1986. p. 193-205.
34. Rudenko LG, Obrosove-Serova NP, Burtseva El, et al. Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia. 1: safety and efficacy in two Moscow schools, 1987-88. Bull WHO 1996;74:77-84.
35. Rudenko LG, Slepushkin AN, Monto AS, et al. Efficacy of live attenuated and inactived influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Inf Dis 1993;168:881-7.
36. Kendal AP. Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries? Eur J Epidemiol 1997;13:591-609.
37. Vesikari T. et al. A randomised, double blind, placebo-controlled trial on the safety, transmissibility and phenotypic stability of a live attenuated cold-adapted Influenza virus vaccine in children attending daycare. 41e ICAAC 2001, Chicago, abstract no G-450.
38. Neuzil KM, DupontWD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against Influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J 2001;20:733-40 [30].
39. Longini IM, Halloran ME, Nizam A, Wolff M, Mendelman PM, Fast PE, et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi center vaccine trial: implications for influenza epidemic control. Vaccine 2000 mars 17;18(18):1902-9.
40. Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmoud K, Reinsinger K, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 2000 Mars;181(3):1133-7.
41. Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmoud K, Reinsinger K, et al. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus infected and noninfected children. Pediatr Infect Dis J 2001;20:1124-31.
42. Redding G, Walker RE, Hessel C, Virant FS, Bensch G, Cordova J, et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2002 j;21:44-8.
43. Marchisio P, Cavagna R, Maspes B, Gironi S, Esposito S, Lambertini L, et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis 2002;35:168-74.
44. Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlezsinger M, et al. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine. J Med Virol 2001;65:178-84.
45. Jacobson RM, Poland GA. Universal vaccination of healthy children against influenza: A role for the Cold-Adapted intranasal influenza vaccine. Paediatr Drugs 2002;4:65-71.
46. Nichol KL. Live attenuated influenza virus vaccines: new options for the prevention of influenza. Vaccine 2001;19:4373-7.
47. Monto AS. Guidelines for the Clinical Use of Antivirals. Text book of influenza. In: Nicholson KG, Webster RG, Hay AJ, editors. Oxford: Blackwell Science; 1998. p. 506-14.
48. Couch RB. A new antiviral agent for influenza -Is there a clinical niche? N Engl J Med 1997;337(13):927-8.
49. Maissner HC. Antiviral drugs for prophylaxis and treatment of influenza. Pediatr Infect Dis J 2001;20(12):1165-7.
50. Laver G, Bischofberger N, Webster R. La lutte contre la grippe. Pour la Science 1999;257:60-9.
51. Whitley RJ, et al. Oral oseltamivir treatment of influenza. Pediatr Infect Dis J 2001;20:127-33.